![](/img/cover-not-exists.png)
A phase I/II trial of capecitabine combined with peginterferon α-2a in Patients with sorafenib-refractory advanced hepatocellular carcinoma
Ogasawara, Sadahisa, Chiba, Tetsuhiro, Ooka, Yoshihiko, Kanogawa, Naoya, Motoyama, Tenyu, Suzuki, Eiichiro, Tawada, Akinobu, Kanai, Fumihiko, Yokosuka, and OsamuVolume:
32
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-014-0097-2
Date:
August, 2014
File:
PDF, 248 KB
english, 2014